Omics profiles in chronic venous ulcer wound fluid: innovative applications for translational medicine

References

• Rabe E, Guex JJ, Puskas A, et al. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol 2012;31(2):105-15
   PubMed Web of Science ®Google Scholar
• Pannier F, Rabe E. The relevance of the natural history of varicose veins and refunded care. Phlebology 2012;27(Suppl 1):23-6
   PubMedGoogle Scholar
• Neglen P, Eklof B, Kulwicki A, et al. Prevention and treatment of venous ulcers in primary chronic venous insufficiency. J Vasc Surg 2010;52(5 Suppl):15S-20S
   Google Scholar
• Moseley R, Stewart JE, Stephens P, et al. Extracellular matrix metabolites as potential biomarkers of disease activity in wound fluid: lessons learned from other inflammatory diseases? Br J Dermatol 2004;150(3):401-13
   PubMed Web of Science ®Google Scholar
• Pukstad BS, Ryan L, Flo TH, et al. Non-healing is associated with persistent stimulation of the innate immune response in chronic venous leg ulcers. J Dermatol Sci 2010;59(2):115-22
   PubMed Web of Science ®Google Scholar
• Moore K, Huddleston E, Stacey MC, Harding KG. Venous leg ulcers - the search for a prognostic indicator. Int Wound J 2007;4(2):163-72
   PubMedGoogle Scholar
• Mannello F, Ligi D, Magnani M. Deciphering the single-cell omic: innovative application for translational medicine. Expert Rev Proteomics 2012;9(6):635-48
   PubMed Web of Science ®Google Scholar
• Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol 2005;15(3):175-84
   PubMed Web of Science ®Google Scholar
• Gloviczki P, Comerota AJ, Dalsing MC, et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011;53(5 Suppl):2S-48S
   PubMedGoogle Scholar
• Carroll C, Hummel S, Leaviss J, et al. Clinical effectiveness and cost-effectiveness of minimally invasive techniques to manage varicose veins: a systematic review and economic evaluation. Health Technol Assess 2013;17(48):i-141
   PubMed Web of Science ®Google Scholar
• Mannello F, Raffetto JD. Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research. Am J Transl Res 2011;3(2):149-58
   PubMed Web of Science ®Google Scholar
• Rabe E, Pannier F. Clinical, aetiological, anatomical and pathological classification (CEAP): gold standard and limits. Phlebology 2012;27(Suppl 1):114-18
   PubMedGoogle Scholar
• Bergan J. Molecular mechanisms in chronic venous insufficiency. Ann Vasc Surg 2007;21(3):260-6
   PubMed Web of Science ®Google Scholar
• Bergan JJ, Schmid-Schonbein GW, Coleridge Smith PD, et al. Chronic venous disease. Minerva Cardioangiol 2007;55(4):459-76
   PubMedGoogle Scholar
• Kahn SR, Ginsberg JS. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med 2004;164(1):17-26
   PubMed Web of Science ®Google Scholar
• Labropoulos N, Mansour MA, Kang SS, et al. New insights into perforator vein incompetence. Eur J Vasc Endovasc Surg 1999;18(3):228-34
   PubMed Web of Science ®Google Scholar
• Delis KT, Husmann M, Kalodiki E, et al. In situ hemodynamics of perforating veins in chronic venous insufficiency. J Vasc Surg 2001;33(4):773-82
   PubMed Web of Science ®Google Scholar
• Nicolaides AN, Allegra C, Bergan J, et al. Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence. Int Angiol 2008;27(1):1-59
   PubMed Web of Science ®Google Scholar
• Bergan JJ, Schmid-Schonbein GW, Smith PD, et al. Chronic venous disease. N Engl J Med 2006;355(5):488-98
   PubMed Web of Science ®Google Scholar
• Lim CS, Davies AH. Pathogenesis of primary varicose veins. Br J Surg 2009;96(11):1231-42
   PubMed Web of Science ®Google Scholar
• Markovic JN, Shortell CK. Genomics of varicose veins and chronic venous insufficiency. Semin Vasc Surg 2013;26(1):2-13
   PubMed Web of Science ®Google Scholar
• Raffetto JD and Mannello F. Pathophysiology of chronic venous disease. Int Angiol 2014; In press
   Web of Science ®Google Scholar
• Oklu R, Habito R, Mayr M, et al. Pathogenesis of varicose veins. J Vasc Interv Radiol 2012;23(1):33-9
   PubMed Web of Science ®Google Scholar
• Mannello F, Ligi D, Canale M, Raffetto JD. Sulodexide down-regulates the release of cytokines, chemokines, and leukocyte colony stimulating factors from human macrophages: role of glycosaminoglycans in inflammatory pathways of chronic venous disease. Curr Vasc Pharmacol 2014;12(1):173-85
   PubMed Web of Science ®Google Scholar
• Nicolaides AN. Chronic venous disease and the leukocyte-endothelium interaction: from symptoms to ulceration. Angiology 2005;56(Suppl 1):S11-19
   Google Scholar
• Saharay M, Shields DA, Porter JB, et al. Leukocyte activity in the microcirculation of the leg in patients with chronic venous disease. J Vasc Surg 1997;26(2):265-73
   PubMed Web of Science ®Google Scholar
• Ono T, Bergan JJ, Schmid-Schonbein GW, Takase S. Monocyte infiltration into venous valves. J Vasc Surg 1998;27(1):158-66
   PubMed Web of Science ®Google Scholar
• Takase S, Bergan JJ, Schmid-Schonbein G. Expression of adhesion molecules and cytokines on saphenous veins in chronic venous insufficiency. Ann Vasc Surg 2000;14(5):427-35
   PubMed Web of Science ®Google Scholar
• Ackerman Z, Seidenbaum M, Loewenthal E, Rubinow A. Overload of iron in the skin of patients with varicose ulcers. Possible contributing role of iron accumulation in progression of the disease. Arch Dermatol 1988;124(9):1376-8
   PubMedGoogle Scholar
• Zamboni P, Izzo M, Tognazzo S, et al. The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis. Free Radic Biol Med 2006;40(10):1869-73
   PubMed Web of Science ®Google Scholar
• Pappas PJ, Lal BK, Ohara N, et al. Regulation of matrix contraction in chronic venous disease. Eur J Vasc Endovasc Surg 2009;38(4):518-29
   PubMed Web of Science ®Google Scholar
• Yeoh-Ellerton S, Stacey MC. Iron and 8-isoprostane levels in acute and chronic wounds. J Invest Dermatol 2003;121(4):918-25
   PubMed Web of Science ®Google Scholar
• Caggiati A, Franceschini M, Heyn R, Rosi C. Skin erythrodiapedesis during chronic venous disorders. J Vasc Surg 2011;53(6):1649-53
   PubMed Web of Science ®Google Scholar
• Zamboni P, Scapoli G, Lanzara V, et al. Serum iron and matrix metalloproteinase-9 variations in limbs affected by chronic venous disease and venous leg ulcers. Dermatol Surg 2005;31(6):644-9
   PubMed Web of Science ®Google Scholar
• Raffetto JD. Inflammation in chronic venous ulcers. Phlebology 2013;28(Suppl 1):61-7
   PubMedGoogle Scholar
• Raffetto JD, Marston WA. Venous ulcer: what is new? Plast Reconstr Surg 2011;127(Suppl 1):279S-88S
   Web of Science ®Google Scholar
• Yasim A, Kilinc M, Aral M, et al. Serum concentration of procoagulant, endothelial and oxidative stress markers in early primary varicose veins. Phlebology 2008;23(1):15-20
   PubMed Web of Science ®Google Scholar
• Shoab SS, Scurr JH, Coleridge-Smith PD. Increased plasma vascular endothelial growth factor among patients with chronic venous disease. J Vasc Surg 1998;28(3):535-40
   PubMed Web of Science ®Google Scholar
• Kowalewski R, Malkowski A, Sobolewski K, Gacko M. Evaluation of transforming growth factor-beta signaling pathway in the wall of normal and varicose veins. Pathobiology 2010;77(1):1-6
   PubMed Web of Science ®Google Scholar
• Pascual G, Corrales C, Gomez-Gil V, et al. TGF-beta1 overexpression in the transversalis fascia of patients with direct inguinal hernia. Eur J Clin Invest 2007;37(6):516-21
   PubMed Web of Science ®Google Scholar
• Sola LR, Aceves M, Duenas AI, et al. Varicose veins show enhanced chemokine expression. Eur J Vasc Endovasc Surg 2009;38(5):635-41
   PubMed Web of Science ®Google Scholar
• Kucukguven A, Khalil RA. Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins. Curr Drug Targets 2013;14(3):287-324
   PubMed Web of Science ®Google Scholar
• Raffetto JD, Khalil RA. Matrix metalloproteinases in venous tissue remodeling and varicose vein formation. Curr Vasc Pharmacol 2008;6(3):158-72
   PubMed Web of Science ®Google Scholar
• Lim CS, Kiriakidis S, Sandison A, et al. Hypoxia-inducible factor pathway and diseases of the vascular wall. J Vasc Surg 2013;58(1):219-30
   PubMed Web of Science ®Google Scholar
• Sansilvestri-Morel P, Fioretti F, Rupin A, et al. Comparison of extracellular matrix in skin and saphenous veins from patients with varicose veins: does the skin reflect venous matrix changes? Clin Sci (Lond) 2007;112(4):229-39
   PubMed Web of Science ®Google Scholar
• Perrin M, Ramelet AA. Pharmacological treatment of primary chronic venous disease: rationale, results and unanswered questions. Eur J Vasc Endovasc Surg 2011;41(1):117-25
   PubMed Web of Science ®Google Scholar
• Jagielska J, Kapopara PR, Salguero G, et al. Interleukin-1 assembles a proangiogenic signaling module consisting of caveolin-1, tumor necrosis factor receptor-associated factor 6, p38-mitogen-activated protein kinase (MAPK), and MAPK-activated protein kinase 2 in endothelial cells. Arterioscler Thromb Vasc Biol 2012;32(5):1280-8
   PubMed Web of Science ®Google Scholar
• Kowalewski R, Sobolewski K, Malkowski A, et al. Glycosaminoglycan-degrading enzymes in the varicose vein wall. Int Angiol 2008;27(6):529-35
   PubMed Web of Science ®Google Scholar
• Wolanska M, Sobolewski K, Glowinski S, et al. Glycosaminoglycans of normal veins and their alterations in varicose veins and varicose veins complicated by thrombophlebitis. Eur Surg Res 2001;33(1):28-32
   PubMed Web of Science ®Google Scholar
• Lundqvist K, Schmidtchen A. Immunohistochemical studies on proteoglycan expression in normal skin and chronic ulcers. Br J Dermatol 2001;144(2):254-9
   PubMed Web of Science ®Google Scholar
• Pappas PJ, DeFouw DO, Venezio LM, et al. Morphometric assessment of the dermal microcirculation in patients with chronic venous insufficiency. J Vasc Surg 1997;26(5):784-95
   PubMed Web of Science ®Google Scholar
• Coccheri S, Mannello F. Development and use of sulodexide in vascular diseases: implications for treatment. Drug Des Devel Ther 2013;8:49-65
   PubMed Web of Science ®Google Scholar
• Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 2009;78(6):539-52
   PubMed Web of Science ®Google Scholar
• Raffetto JD, Khalil RA. Mechanisms of varicose vein formation: valve dysfunction and wall dilation. Phlebology 2008;23(2):85-98
   PubMed Web of Science ®Google Scholar
• Raffetto JD, Ross RL, Khalil RA. Matrix metalloproteinase 2-induced venous dilation via hyperpolarization and activation of K+ channels: relevance to varicose vein formation. J Vasc Surg 2007;45(2):373-80
   PubMed Web of Science ®Google Scholar
• Raffetto JD, Yu P, Reslan OM, et al. Endothelium-dependent nitric oxide and hyperpolarization-mediated venous relaxation pathways in rat inferior vena cava. J Vasc Surg 2012;55(6):1716-25
   PubMed Web of Science ®Google Scholar
• Agren MS, Eaglstein WH, Ferguson MW, et al. Causes and effects of the chronic inflammation in venous leg ulcers. Acta Derm Venereol Suppl (Stockh) 2000;210:3-17
   PubMedGoogle Scholar
• Widgerow AD. Chronic wound fluid – thinking outside the box. Wound Repair Regen 2011;19(3):287-91
   PubMed Web of Science ®Google Scholar
• Chatterjee SS. Venous ulcers of the lower limb: Where do we stand? Indian J Plast Surg 2012;45(2):266-74
   PubMedGoogle Scholar
• Peschen M, Lahaye T, Hennig B, et al. Expression of the adhesion molecules ICAM-1, VCAM-1, LFA-1 and VLA-4 in the skin is modulated in progressing stages of chronic venous insufficiency. Acta Derm Venereol 1999;79(1):27-32
   PubMed Web of Science ®Google Scholar
• Weyl A, Vanscheidt W, Weiss JM, et al. Expression of the adhesion molecules ICAM-1, VCAM-1, and E-selectin and their ligands VLA-4 and LFA-1 in chronic venous leg ulcers. J Am Acad Dermatol 1996;34(3):418-23
   PubMed Web of Science ®Google Scholar
• Simka M. Cellular and molecular mechanisms of venous leg ulcers development – the “puzzle” theory. Int Angiol 2010;29(1):1-19
   PubMed Web of Science ®Google Scholar
• Baker EA, Leaper DJ. Proteinases, their inhibitors, and cytokine profiles in acute wound fluid. Wound Repair Regen 2000;8(5):392-8
   PubMed Web of Science ®Google Scholar
• Loots MA, Lamme EN, Zeegelaar J, et al. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol 1998;111(5):850-7
   PubMed Web of Science ®Google Scholar
• Jones KR. Why do chronic venous leg ulcers not heal? J Nurs Care Qual 2009;24(2):116-24
   PubMed Web of Science ®Google Scholar
• Barrientos S, Stojadinovic O, Golinko MS, et al. Growth factors and cytokines in wound healing. Wound Repair Regen 2008;16(5):585-601
   PubMed Web of Science ®Google Scholar
• Cullen B, Watt PW, Lundqvist C, et al. The role of oxidised regenerated cellulose/collagen in chronic wound repair and its potential mechanism of action. Int J Biochem Cell Biol 2002;34(12):1544-56
   PubMed Web of Science ®Google Scholar
• Cullen B, Smith R, McCulloch E, et al. Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Repair Regen 2002;10(1):16-25
   PubMed Web of Science ®Google Scholar
• Widgerow AD. Chronic wounds - is cellular ‘reception’ at fault? Examining integrins and intracellular signalling. Int Wound J 2013;10(2):185-92
   PubMed Web of Science ®Google Scholar
• Bergan JJ, Pascarella L, Schmid-Schonbein GW. Pathogenesis of primary chronic venous disease: insights from animal models of venous hypertension. J Vasc Surg 2008;47(1):183-92
   PubMed Web of Science ®Google Scholar
• Robnett AH. Chronic ulcers of the leg of venous origin. Cleve Clin Q 1955;22(1):3-9
   PubMedGoogle Scholar
• Lozano Sanchez FS, Marinello RJ, Carrasco CE, et al. Venous leg ulcer in the context of chronic venous disease. Phlebology 2014;29(4):220-6
   PubMed Web of Science ®Google Scholar
• Eming SA, Koch M, Krieger A, et al. Differential proteomic analysis distinguishes tissue repair biomarker signatures in wound exudates obtained from normal healing and chronic wounds. J Proteome Res 2010;9(9):4758-66
   PubMed Web of Science ®Google Scholar
• Phillips TJ, al-Amoudi HO, Leverkus M, Park HY. Effect of chronic wound fluid on fibroblasts. J Wound Care 1998;7(10):527-32
   PubMedGoogle Scholar
• Seah CC, Phillips TJ, Howard CE, et al. Chronic wound fluid suppresses proliferation of dermal fibroblasts through a Ras-mediated signaling pathway. J Invest Dermatol 2005;124(2):466-74
   PubMed Web of Science ®Google Scholar
• Fernandez ML, Broadbent JA, Shooter GK, et al. Development of an enhanced proteomic method to detect prognostic and diagnostic markers of healing in chronic wound fluid. Br J Dermatol 2008;158(2):281-90
   PubMed Web of Science ®Google Scholar
• Escalante T, Rucavado A, Pinto AF, et al. Wound exudate as a proteomic window to reveal different mechanisms of tissue damage by snake venom toxins. J Proteome Res 2009;8(11):5120-31
   PubMed Web of Science ®Google Scholar
• Wyffels JT, Fries KM, Randall JS, et al. Analysis of pressure ulcer wound fluid using two-dimensional electrophoresis. Int Wound J 2010;7(4):236-48
   PubMed Web of Science ®Google Scholar
• Edsberg LE, Wyffels JT, Brogan MS, Fries KM. Analysis of the proteomic profile of chronic pressure ulcers. Wound Repair Regen 2012;20(3):378-401
   PubMed Web of Science ®Google Scholar
• Krysa J, Jones GT, van Rij AM. Evidence for a genetic role in varicose veins and chronic venous insufficiency. Phlebology 2012;27(7):329-35
   PubMed Web of Science ®Google Scholar
• Anwar MA, Georgiadis KA, Shalhoub J, et al. A review of familial, genetic, and congenital aspects of primary varicose vein disease. Circ Cardiovasc Genet 2012;5(4):460-6
   PubMedGoogle Scholar
• Cornu-Thenard A, Boivin P, Baud JM, De V. I, Carpentier PH. Importance of the familial factor in varicose disease. Clinical study of 134 families. J Dermatol Surg Oncol 1994;20(5):318-26
   PubMedGoogle Scholar
• Serra R, Buffone G, de FA, et al. A genetic study of chronic venous insufficiency. Ann Vasc Surg 2012;26(5):636-42
   PubMed Web of Science ®Google Scholar
• Zamboni P, Tognazzo S, Izzo M, et al. Hemochromatosis C282Y gene mutation increases the risk of venous leg ulceration. J Vasc Surg 2005;42(2):309-14
   PubMed Web of Science ®Google Scholar
• Tognazzo S, Gemmati D, Palazzo A, et al. Prognostic role of factor XIII gene variants in nonhealing venous leg ulcers. J Vasc Surg 2006;44(4):815-19
   PubMed Web of Science ®Google Scholar
• Gemmati D, Tognazzo S, Serino ML, et al. Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension. Wound Repair Regen 2004;12(5):512-17
   PubMed Web of Science ®Google Scholar
• Zamboni P, De MM, Ongaro A, et al. Factor XIII contrasts the effects of metalloproteinases in human dermal fibroblast cultured cells. Vasc Endovascular Surg 2004;38(5):431-8
   PubMedGoogle Scholar
• Gemmati D, Tognazzo S, Catozzi L, et al. Influence of gene polymorphisms in ulcer healing process after superficial venous surgery. J Vasc Surg 2006;44(3):554-62
   PubMed Web of Science ®Google Scholar
• Xu HM, Zhao Y, Zhang XM, et al. Polymorphisms in MMP-9 and TIMP-2 in Chinese patients with varicose veins. J Surg Res 2011;168(1):e143-8
   PubMed Web of Science ®Google Scholar
• Yin H, Zhang X, Wang J, et al. Downregulation of desmuslin in primary vein incompetence. J Vasc Surg 2006;43(2):372-8
   PubMed Web of Science ®Google Scholar
• Lee S, Lee W, Choe Y, et al. Gene expression profiles in varicose veins using complementary DNA microarray. Dermatol Surg 2005;31(4):391-5
   PubMed Web of Science ®Google Scholar
• Le FL, Mennen L, Aubry ML, et al. Thrombomodulin promoter mutations, venous thrombosis, and varicose veins. Arterioscler Thromb Vasc Biol 2001;21(3):445-51
   PubMed Web of Science ®Google Scholar
• Cui C, Liu G, Huang Y, et al. MicroRNA profiling in great saphenous vein tissues of patients with chronic venous insufficiency. Tohoku J Exp Med 2012;228(4):341-50
   PubMed Web of Science ®Google Scholar
• Escandon J, Vivas AC, Perez R, et al. A prospective pilot study of ultrasound therapy effectiveness in refractory venous leg ulcers. Int Wound J 2012;9(5):570-8
   PubMed Web of Science ®Google Scholar
• Grzela T, Bialoszewska A. Genetic risk factors of chronic venous leg ulceration: Can molecular screening aid in the prevention of chronic venous insufficiency complications? Mol Med Rep 2010;3(2):205-11
   PubMed Web of Science ®Google Scholar
• Hamdan A. Management of varicose veins and venous insufficiency. JAMA 2012;308(24):2612-21
   PubMed Web of Science ®Google Scholar
• Staiano-Coico L, Higgins PJ, Schwartz SB, et al. Wound fluids: a reflection of the state of healing. Ostomy Wound Manage 2000;46(1A Suppl):85S-93S
   Google Scholar
• Breslow R. Nutritional status and dietary intake of patients with pressure ulcers: review of research literature 1943 to 1989. Decubitus 1991;4(1):16-21
   PubMedGoogle Scholar
• Breslow RA, Bergstrom N. Nutritional prediction of pressure ulcers. J Am Diet Assoc 1994;94(11):1301-4
   PubMedGoogle Scholar
• Stotts NA, Wipke-Tevis D. Nutrition perfusion, and wound healing: an inseparable triad. Nutrition 1996;12(10):733-4
   PubMed Web of Science ®Google Scholar
• Wipke-Tevis DD, Stotts NA. Nutritional risk, status, and intake of individuals with venous ulcers: a pilot study. J Vasc Nurs 1996;14(2):27-33
   PubMedGoogle Scholar
• James TJ, Hughes MA, Cherry GW, Taylor RP. Simple biochemical markers to assess chronic wounds. Wound Repair Regen 2000;8(4):264-9
   PubMed Web of Science ®Google Scholar
• Moseley R, Hilton JR, Waddington RJ, et al. Comparison of oxidative stress biomarker profiles between acute and chronic wound environments. Wound Repair Regen 2004;12(4):419-29
   PubMed Web of Science ®Google Scholar
• bd-El-Aleem SA, Ferguson MW, Appleton I, et al. Expression of cyclooxygenase isoforms in normal human skin and chronic venous ulcers. J Pathol 2001;195(5):616-23
   PubMed Web of Science ®Google Scholar
• Ghaderian SM, Lindsey NJ, Graham AM, et al. Pathogenic mechanisms in varicose vein disease: the role of hypoxia and inflammation. Pathology 2010;42(5):446-53
   PubMed Web of Science ®Google Scholar
• bd-El-Aleem SA, Ferguson MW, Appleton I, et al. Expression of nitric oxide synthase isoforms and arginase in normal human skin and chronic venous leg ulcers. J Pathol 2000;191(4):434-42
   PubMed Web of Science ®Google Scholar
• Luk PP, Sinha SN, Lord R. Upregulation of inducible nitric oxide synthase (iNOS) expression in faster-healing chronic leg ulcers. J Wound Care 2005;14(8):373-81
   PubMedGoogle Scholar
• Wlaschek M, Scharffetter-Kochanek K. Oxidative stress in chronic venous leg ulcers. Wound Repair Regen 2005;13(5):452-61
   PubMed Web of Science ®Google Scholar
• Zamboni P, Lanzara S, Mascoli F, et al. Inflammation in venous disease. Int Angiol 2008;27(5):361-9
   PubMed Web of Science ®Google Scholar
• Allhorn M, Lundqvist K, Schmidtchen A, Akerstrom B. Heme-scavenging role of alpha1-microglobulin in chronic ulcers. J Invest Dermatol 2003;121(3):640-6
   PubMed Web of Science ®Google Scholar
• Myers HL. Topical chelation therapy for varicose pigmentation. Angiology 1966;17(1):66-8
   PubMed Web of Science ®Google Scholar
• Wenk J, Foitzik A, Achterberg V, et al. Selective pick-up of increased iron by deferoxamine-coupled cellulose abrogates the iron-driven induction of matrix-degrading metalloproteinase 1 and lipid peroxidation in human dermal fibroblasts in vitro: a new dressing concept. J Invest Dermatol 2001;116(6):833-9
   PubMed Web of Science ®Google Scholar
• Ammons MC, Copie V. Mini-review: lactoferrin: a bioinspired, anti-biofilm therapeutic. Biofouling 2013;29(4):443-55
   PubMed Web of Science ®Google Scholar
• Moor AN, Vachon DJ, Gould LJ. Proteolytic activity in wound fluids and tissues derived from chronic venous leg ulcers. Wound Repair Regen 2009;17(6):832-9
   PubMed Web of Science ®Google Scholar
• Hasmann A, Wehrschuetz-Sigl E, Marold A, et al. Analysis of myeloperoxidase activity in wound fluids as a marker of infection. Ann Clin Biochem 2013;50(Pt 3):245-54
   PubMed Web of Science ®Google Scholar
• Lundqvist K, Herwald H, Sonesson A, Schmidtchen A. Heparin binding protein is increased in chronic leg ulcer fluid and released from granulocytes by secreted products of Pseudomonas aeruginosa. Thromb Haemost 2004;92(2):281-7
   PubMed Web of Science ®Google Scholar
• Lundqvist K, Sorensen OE, Schmidtchen A. Increased levels of human neutrophil alpha-defensins in chronic venous leg ulcers. J Dermatol Sci 2008;51(2):131-4
   PubMed Web of Science ®Google Scholar
• Trostrup H, Lundquist R, Christensen LH, et al. S100A8/A9 deficiency in nonhealing venous leg ulcers uncovered by multiplexed antibody microarray profiling. Br J Dermatol 2011;165(2):292-301
   PubMed Web of Science ®Google Scholar
• Haukipuro K. Synthesis of collagen types I and III in reincised wounds in humans. Br J Surg 1991;78(6):708-12
   PubMed Web of Science ®Google Scholar
• Haukipuro K, Melkko J, Risteli L, et al. Synthesis of type I collagen in healing wounds in humans. Ann Surg 1991;213(1):75-80
   PubMed Web of Science ®Google Scholar
• Rasmussen LH, Jensen LT, Avnstorp C, et al. Collagen types I and III propeptides as markers of healing in chronic leg ulcers. A noninvasive method for the determination of procollagen propeptides in wound fluid – influence of growth hormone. Ann Surg 1992;216(6):684-91
   PubMed Web of Science ®Google Scholar
• Meyer FJ, Burnand KG, Abisi S, et al. Effect of collagen turnover and matrix metalloproteinase activity on healing of venous leg ulcers. Br J Surg 2008;95(3):319-25
   PubMed Web of Science ®Google Scholar
• Gallo R, Kim C, Kokenyesi R, et al. Syndecans-1 and -4 are induced during wound repair of neonatal but not fetal skin. J Invest Dermatol 1996;107(5):676-83
   PubMed Web of Science ®Google Scholar
• Subramanian SV, Fitzgerald ML, Bernfield M. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. J Biol Chem 1997;272(23):14713-20
   PubMed Web of Science ®Google Scholar
• Kainulainen V, Wang H, Schick C, Bernfield M. Syndecans, heparan sulfate proteoglycans, maintain the proteolytic balance of acute wound fluids. J Biol Chem 1998;273(19):11563-9
   PubMed Web of Science ®Google Scholar
• Grinnell F, Ho CH, Wysocki A. Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting, and cell adhesion assays. J Invest Dermatol 1992;98(4):410-16
   PubMed Web of Science ®Google Scholar
• Latijnhouwers MA, Bergers M, Veenhuis RT. Beekman B, nkersmit-Ter Horst MF, Schalkwijk J. Tenascin-C degradation in chronic wounds is dependent on serine proteinase activity. Arch Dermatol Res 1998;290(9):490-6
   PubMed Web of Science ®Google Scholar
• Trengove NJ, Bielefeldt-Ohmann H, Stacey MC. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen 2000;8(1):13-25
   PubMed Web of Science ®Google Scholar
• Wiegand C, Schonfelder U, Abel M, et al. Protease and pro-inflammatory cytokine concentrations are elevated in chronic compared to acute wounds and can be modulated by collagen type I in vitro. Arch Dermatol Res 2010;302(6):419-28
   PubMed Web of Science ®Google Scholar
• Gartner MH, Shearer JD, Bereiter DF, et al. Wound fluid amino acid concentrations regulate the effect of epidermal growth factor on fibroblast replication. Surgery 1991;110(2):448-55
   PubMed Web of Science ®Google Scholar
• Stechmiller JK, Childress B, Cowan L. Arginine supplementation and wound healing. Nutr Clin Pract 2005;20(1):52-61
   PubMedGoogle Scholar
• Childress B, Stechmiller JK, Schultz GS. Arginine metabolites in wound fluids from pressure ulcers: a pilot study. Biol Res Nurs 2008;10(2):87-92
   PubMed Web of Science ®Google Scholar
• Trengove NJ, Langton SR, Stacey MC. Biochemical analysis of wound fluid from nonhealing and healing chronic leg ulcers. Wound Repair Regen 1996;4(2):234-9
   PubMedGoogle Scholar
• Fernandez ML, Upton Z, Edwards H, et al. Elevated uric acid correlates with wound severity. Int Wound J 2012;9(2):139-49
   PubMed Web of Science ®Google Scholar
• Fernandez ML, Upton Z, Shooter GK. Uric Acid and xanthine oxidoreductase in wound healing. Curr Rheumatol Rep 2014;16(2):396
   PubMed Web of Science ®Google Scholar
• Dodd H. The chronic venous disorders of the lower limb (or varicose veins and ulceration of the leg). J R Inst Public Health 1958;21(2):39-47
   PubMedGoogle Scholar
• Dormandy A. Pathophysiology of venous leg ulceration. Int J Microcirc Clin Exp 1997;17(Suppl 1):2-5
   PubMedGoogle Scholar
• James TJ, Hughes MA, Hofman D, et al. Antioxidant characteristics of chronic wound fluid. Br J Dermatol 2001;145(1):185-6
   PubMed Web of Science ®Google Scholar
• James TJ, Hughes MA, Cherry GW, Taylor RP. Evidence of oxidative stress in chronic venous ulcers. Wound Repair Regen 2003;11(3):172-6
   PubMed Web of Science ®Google Scholar
• Anwar MA, Shalhoub J, Vorkas PA, et al. In-vitro identification of distinctive metabolic signatures of intact varicose vein tissue via magic angle spinning nuclear magnetic resonance spectroscopy. Eur J Vasc Endovasc Surg 2012;44(4):442-50
   PubMed Web of Science ®Google Scholar
• Lopez-Otin C, Overall CM. Protease degradomics: a new challenge for proteomics. Nat Rev Mol Cell Biol 2002;3(7):509-19
   PubMed Web of Science ®Google Scholar
• Strlic M, Thomas J, Trafela T, et al. Material degradomics: on the smell of old books. Anal Chem 2009;81(20):8617-22
   PubMed Web of Science ®Google Scholar
• Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008;75(2):346-59
   PubMed Web of Science ®Google Scholar
• Moali C, Hulmes DJ. Extracellular and cell surface proteases in wound healing: new players are still emerging. Eur J Dermatol 2009;19(6):552-64
   PubMed Web of Science ®Google Scholar
• Toriseva M, Kahari VM. Proteinases in cutaneous wound healing. Cell Mol Life Sci 2009;66(2):203-24
   PubMed Web of Science ®Google Scholar
• Hermes O, Schlage P, auf dem KU. Wound degradomics - current status and future perspectives. Biol Chem 2011;392(11):949-54
   PubMed Web of Science ®Google Scholar
• Barrick B, Campbell EJ, Owen CA. Leukocyte proteinases in wound healing: roles in physiologic and pathologic processes. Wound Repair Regen 1999;7(6):410-22
   PubMed Web of Science ®Google Scholar
• Herouy Y, Trefzer D, Hellstern MO, et al. Plasminogen activation in venous leg ulcers. Br J Dermatol 2000;143(5):930-6
   PubMed Web of Science ®Google Scholar
• Herouy Y, Trefzer D, Zimpfer U, et al. Matrix metalloproteinases and venous leg ulceration. Eur J Dermatol 2000;10(3):173-80
   PubMed Web of Science ®Google Scholar
• Campbell EJ, Cury JD, Shapiro SD, et al. Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. J Immunol 1991;146(4):1286-93
   PubMed Web of Science ®Google Scholar
• Claudy AL, Mirshahi M, Soria C, Soria J. Detection of undegraded fibrin and tumor necrosis factor-alpha in venous leg ulcers. J Am Acad Dermatol 1991;25(4):623-7
   PubMed Web of Science ®Google Scholar
• Wysocki AB, Staiano-Coico L, Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 1993;101(1):64-8
   PubMed Web of Science ®Google Scholar
• Rogers AA, Burnett S, Moore JC, et al. Involvement of proteolytic enzymes – plasminogen activators and matrix metalloproteinases – in the pathophysiology of pressure ulcers. Wound Repair Regen 1995;3(3):273-83
   PubMedGoogle Scholar
• Kowalewski R, Sobolewski K, Wolanska M, Gacko M. Matrix metalloproteinases in the vein wall. Int Angiol 2004;23(2):164-9
   PubMed Web of Science ®Google Scholar
• Trengove NJ, Stacey MC, MacAuley S, et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 1999;7(6):442-52
   PubMed Web of Science ®Google Scholar
• Agren MS. Gelatinase activity during wound healing. Br J Dermatol 1994;131(5):634-40
   PubMed Web of Science ®Google Scholar
• Bullen EC, Longaker MT, Updike DL, et al. Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol 1995;104(2):236-40
   PubMed Web of Science ®Google Scholar
• Wysocki AB, Kusakabe AO, Chang S, Tuan TL. Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing. Wound Repair Regen 1999;7(3):154-65
   PubMed Web of Science ®Google Scholar
• Wysocki AB, Grinnell F. Fibronectin profiles in normal and chronic wound fluid. Lab Invest 1990;63(6):825-31
   PubMed Web of Science ®Google Scholar
• Palolahti M, Lauharanta J, Stephens RW, et al. Proteolytic activity in leg ulcer exudate. Exp Dermatol 1993;2(1):29-37
   PubMedGoogle Scholar
• McCarty SM, Cochrane CA, Clegg PD, Percival SL. The role of endogenous and exogenous enzymes in chronic wounds: a focus on the implications of aberrant levels of both host and bacterial proteases in wound healing. Wound Repair Regen 2012;20(2):125-36
   PubMed Web of Science ®Google Scholar
• Nwomeh BC, Liang HX, Cohen IK, Yager DR. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. J Surg Res 1999;81(2):189-95
   PubMed Web of Science ®Google Scholar
• Grinnell F, Zhu M, Parks WC. Collagenase-1 complexes with alpha2-macroglobulin in the acute and chronic wound environments. J Invest Dermatol 1998;110(5):771-6
   PubMed Web of Science ®Google Scholar
• Weckroth M, Vaheri A, Lauharanta J, et al. Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. J Invest Dermatol 1996;106(5):1119-24
   PubMed Web of Science ®Google Scholar
• Amato B, Coretti G, Compagna R, et al. Role of matrix metalloproteinases in non-healing venous ulcers. Int Wound J (in press 2014
   Google Scholar
• Yager DR, Zhang LY, Liang HX, et al. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 1996;107(5):743-8
   PubMed Web of Science ®Google Scholar
• Moues CM, van Toorenenbergen AW, Heule F, et al. The role of topical negative pressure in wound repair: expression of biochemical markers in wound fluid during wound healing. Wound Repair Regen 2008;16(4):488-94
   PubMed Web of Science ®Google Scholar
• Rayment EA, Upton Z, Shooter GK. Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer. Br J Dermatol 2008;158(5):951-61
   PubMed Web of Science ®Google Scholar
• Serra R, Buffone G, Falcone D, et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin. Wound Repair Regen 2013;21(3):395-401
   PubMed Web of Science ®Google Scholar
• Tarlton JF, Bailey AJ, Crawford E, et al. Prognostic value of markers of collagen remodeling in venous ulcers. Wound Repair Regen 1999;7(5):347-55
   PubMed Web of Science ®Google Scholar
• Agren MS, Jorgensen LN, Andersen M, et al. Matrix metalloproteinase 9 level predicts optimal collagen deposition during early wound repair in humans. Br J Surg 1998;85(1):68-71
   PubMed Web of Science ®Google Scholar
• Hoffman R, Noble J, Eagle M. The use of proteases as prognostic markers for the healing of venous leg ulcers. J Wound Care 1999;8(6):273-6
   PubMedGoogle Scholar
• Hoffman R, Starkey S, Coad J. Wound fluid from venous leg ulcers degrades plasminogen and reduces plasmin generation by keratinocytes. J Invest Dermatol 1998;111(6):1140-4
   PubMed Web of Science ®Google Scholar
• Ladwig GP, Robson MC, Liu R, et al. Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Repair Regen 2002;10(1):26-37
   PubMed Web of Science ®Google Scholar
• Mwaura B, Mahendran B, Hynes N, et al. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers. Eur J Vasc Endovasc Surg 2006;31(3):306-10
   PubMed Web of Science ®Google Scholar
• Barone EJ, Yager DR, Pozez AL, et al. Interleukin-1alpha and collagenase activity are elevated in chronic wounds. Plast Reconstr Surg 1998;102(4):1023-7
   PubMedGoogle Scholar
• Brook I, Frazier EH. Aerobic and anaerobic microbiology of chronic venous ulcers. Int J Dermatol 1998;37(6):426-8
   PubMed Web of Science ®Google Scholar
• Grayson LS, Hansbrough JF, Zapata-Sirvent RL, et al. Quantitation of cytokine levels in skin graft donor site wound fluid. Burns 1993;19(5):401-5
   PubMed Web of Science ®Google Scholar
• Gohel MS, Taylor M, Earnshaw JJ, et al. Risk factors for delayed healing and recurrence of chronic venous leg ulcers – an analysis of 1324 legs. Eur J Vasc Endovasc Surg 2005;29(1):74-7
   PubMed Web of Science ®Google Scholar
• Gohel MS, Windhaber RA, Tarlton JF, et al. The relationship between cytokine concentrations and wound healing in chronic venous ulceration. J Vasc Surg 2008;48(5):1272-7
   PubMed Web of Science ®Google Scholar
• Harris IR, Yee KC, Walters CE, et al. Cytokine and protease levels in healing and non-healing chronic venous leg ulcers. Exp Dermatol 1995;4(6):342-9
   PubMedGoogle Scholar
• Tian YW, Stacey MC. Cytokines and growth factors in keratinocytes and sweat glands in chronic venous leg ulcers. An immunohistochemical study. Wound Repair Regen 2003;11(5):316-25
   PubMed Web of Science ®Google Scholar
• Tisato V, Zauli G, Voltan R, et al. Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype. PLoS One 2012;7(6):e39543
   PubMed Web of Science ®Google Scholar
• Fivenson DP, Faria DT, Nickoloff BJ, et al. Chemokine and inflammatory cytokine changes during chronic wound healing. Wound Repair Regen 1997;5(4):310-22
   PubMedGoogle Scholar
• Beidler SK, Douillet CD, Berndt DF, et al. Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy. J Vasc Surg 2009;49(4):1013-20
   PubMed Web of Science ®Google Scholar
• Tisato V, Zamboni P, Menegatti E, et al. Endothelial PDGF-BB produced ex vivo correlates with relevant hemodynamic parameters in patients affected by chronic venous disease. Cytokine 2013;63(2):92-6
   PubMed Web of Science ®Google Scholar
• Peschen M, Grenz H, Brand-Saberi B, et al. Increased expression of platelet-derived growth factor receptor alpha and beta and vascular endothelial growth factor in the skin of patients with chronic venous insufficiency. Arch Dermatol Res 1998;290(6):291-7
   PubMed Web of Science ®Google Scholar
• Peschen M, Grenz H, Grothe C, et al. Patterns of epidermal growth factor receptor, basic fibroblast growth factor and transforming growth factor-beta3 expression in skin with chronic venous insufficiency. Eur J Dermatol 1998;8(5):334-8
   PubMed Web of Science ®Google Scholar
• Agren MS, Steenfos HH, Dabelsteen S, et al. Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated from chronic venous leg ulcers is ulcer-age dependent. J Invest Dermatol 1999;112(4):463-9
   PubMed Web of Science ®Google Scholar
• Cowin AJ, Hatzirodos N, Holding CA, et al. Effect of healing on the expression of transforming growth factor beta(s) and their receptors in chronic venous leg ulcers. J Invest Dermatol 2001;117(5):1282-9
   PubMed Web of Science ®Google Scholar
• Vasquez R, Marien BJ, Gram C, et al. Proliferative capacity of venous ulcer wound fibroblasts in the presence of platelet-derived growth factor. Vasc Endovascular Surg 2004;38(4):355-60
   PubMedGoogle Scholar
• Gillespie DL, Kistner B, Glass C, et al. Venous ulcer diagnosis, treatment, and prevention of recurrences. J Vasc Surg 2010;52(5 Suppl):8S-14S
   Google Scholar
• Hasan A, Murata H, Falabella A, et al. Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-beta 1. J Dermatol Sci 1997;16(1):59-66
   PubMed Web of Science ®Google Scholar
• Kim BC, Kim HT, Park SH, et al. Fibroblasts from chronic wounds show altered TGF-beta-signaling and decreased TGF-beta Type II receptor expression. J Cell Physiol 2003;195(3):331-6
   PubMed Web of Science ®Google Scholar
• Seidman C, Raffetto JD, Marien B, et al. bFGF-induced alterations in cellular markers of senescence in growth-rescued fibroblasts from chronic venous ulcer and venous reflux patients. Ann Vasc Surg 2003;17(3):239-44
   PubMed Web of Science ®Google Scholar
• Kowalewski R, Malkowski A, Sobolewski K, Gacko M. Evaluation of aFGF/bFGF and FGF signaling pathway in the wall of varicose veins. J Surg Res 2009;155(1):165-72
   PubMed Web of Science ®Google Scholar
• Seidman C, Raffetto JD, Overman KC, Menzoian JO. Venous ulcer fibroblasts respond to basic fibroblast growth factor at the cell cycle protein level. Ann Vasc Surg 2006;20(3):376-80
   PubMed Web of Science ®Google Scholar
• Mast BA, Schultz GS. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen 1996;4(4):411-20
   PubMedGoogle Scholar
• Lim M, Goldstein MH, Tuli S, Schultz GS. Growth factor, cytokine and protease interactions during corneal wound healing. Ocul Surf 2003;1(2):53-65
   PubMedGoogle Scholar
• Schultz GS, Wysocki A. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen 2009;17(2):153-62
   PubMed Web of Science ®Google Scholar
• Schultz GS, Davidson JM, Kirsner RS, et al. Dynamic reciprocity in the wound microenvironment. Wound Repair Regen 2011;19(2):134-48
   PubMed Web of Science ®Google Scholar
• McDaniel JC, Roy S, Wilgus TA. Neutrophil activity in chronic venous leg ulcers – a target for therapy? Wound Repair Regen 2013;21(3):339-51
   PubMed Web of Science ®Google Scholar
• Lauer G, Sollberg S, Cole M, et al. Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J Invest Dermatol 2000;115(1):12-18
   PubMed Web of Science ®Google Scholar
• Raffetto JD, Vasquez R, Goodwin DG, Menzoian JO. Mitogen-activated protein kinase pathway regulates cell proliferation in venous ulcer fibroblasts. Vasc Endovascular Surg 2006;40(1):59-66
   PubMedGoogle Scholar
• Raffetto JD, Gram CH, Overman KC, Menzoian JO. Mitogen-activated protein kinase p38 pathway in venous ulcer fibroblasts. Vasc Endovascular Surg 2008;42(4):367-74
   PubMed Web of Science ®Google Scholar
• Moore K, Ruge F, Harding KG. T lymphocytes and the lack of activated macrophages in wound margin biopsies from chronic leg ulcers. Br J Dermatol 1997;137(2):188-94
   PubMed Web of Science ®Google Scholar
• Boyce DE, Jones WD, Ruge F, et al. The role of lymphocytes in human dermal wound healing. Br J Dermatol 2000;143(1):59-65
   PubMed Web of Science ®Google Scholar
• Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011;11(11):723-37
   PubMed Web of Science ®Google Scholar
• Cirino G, Napoli C, Bucci M, Cicala C. Inflammation-coagulation network: are serine protease receptors the knot? Trends Pharmacol Sci 2000;21(5):170-2
   PubMed Web of Science ®Google Scholar
• Overall CM, Lopez-Otin C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2002;2(9):657-72
   PubMed Web of Science ®Google Scholar
• Raffetto JD, Khalil RA. Ca(2+)-dependent contraction by the saponoside escin in rat vena cava: implications in venotonic treatment of varicose veins. J Vasc Surg 2011;54(2):489-96
   PubMed Web of Science ®Google Scholar
• Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation 2005;111(18):2398-409
   PubMed Web of Science ®Google Scholar
• Mannello F, Medda V, Ligi D, Raffetto JD. Glycosaminoglycan sulodexide inhibition of MMP-9 gelatinase secretion and activity: possible pharmacological role against collagen degradation in vascular chronic diseases. Curr Vasc Pharmacol 2013;11(3):354-65
   PubMed Web of Science ®Google Scholar
• Mannello F, Ligi D, Raffetto JD. Glycosaminoglycan sulodexide modulates inflammatory pathways in chronic venous disease. IntAngiol in press 2014
   Google Scholar
• Katz MH, Alvarez AF, Kirsner RS, et al. Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growth. J Am Acad Dermatol 1991;25(6 Pt 1):1054-8
   PubMed Web of Science ®Google Scholar
• Tarnuzzer RW, Schultz GS. Biochemical analysis of acute and chronic wound environments. Wound Repair Regen 1996;4(3):321-5
   PubMedGoogle Scholar
• Cooper DM, Yu EZ, Hennessey P, et al. Determination of endogenous cytokines in chronic wounds. Ann Surg 1994;219(6):688-91
   PubMed Web of Science ®Google Scholar
• Kirsner RS, Marston WA, Snyder RJ, et al. Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2012;380(9846):977-85
   PubMed Web of Science ®Google Scholar
• Lantis JC, Marston WA, Farber A, et al. The influence of patient and wound variables on healing of venous leg ulcers in a randomized controlled trial of growth-arrested allogeneic keratinocytes and fibroblasts. J Vasc Surg 2013;58(2):433-9
   PubMed Web of Science ®Google Scholar
• Grinnell F, Zhu M. Fibronectin degradation in chronic wounds depends on the relative levels of elastase, alpha1-proteinase inhibitor, and alpha2-macroglobulin. J Invest Dermatol 1996;106(2):335-41
   PubMed Web of Science ®Google Scholar
• Herrick S, Ashcroft G, Ireland G, et al. Up-regulation of elastase in acute wounds of healthy aged humans and chronic venous leg ulcers are associated with matrix degradation. Lab Invest 1997;77(3):281-8
   PubMed Web of Science ®Google Scholar
• Schmidtchen A. Degradation of antiproteinases, complement and fibronectin in chronic leg ulcers. Acta Derm Venereol 2000;80(3):179-84
   PubMed Web of Science ®Google Scholar
• Vaalamo M, Leivo T, Saarialho-Kere U. Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Hum Pathol 1999;30(7):795-802
   PubMed Web of Science ®Google Scholar